Angiotensin II receptor blockers in the prevention of complications from atrial fibrillation

Atrial fibrillation (AF) is the most common form of cardiac arrhythmia and is associated with an increased risk of cardiovascular morbidity and mortality, especially due to ischemic stroke. The occurrence of AF leads to atrial electrical and structural remodeling. The renin-angiotensin system appear...

Descripción completa

Detalles Bibliográficos
Autores principales: Naccarelli, Gerald V, Peacock, Frank
Formato: Texto
Lenguaje:English
Publicado: Dove Medical Press 2009
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2747397/
https://www.ncbi.nlm.nih.gov/pubmed/19774220
_version_ 1782172084766507008
author Naccarelli, Gerald V
Peacock, Frank
author_facet Naccarelli, Gerald V
Peacock, Frank
author_sort Naccarelli, Gerald V
collection PubMed
description Atrial fibrillation (AF) is the most common form of cardiac arrhythmia and is associated with an increased risk of cardiovascular morbidity and mortality, especially due to ischemic stroke. The occurrence of AF leads to atrial electrical and structural remodeling. The renin-angiotensin system appears to play a role in the development of atrial arrhythmias by its involvement in both of these processes. Large-scale hypertension trials and heart failure trials have indicated the potential value of angiotensin II receptor blockers in the treatment of AF.
format Text
id pubmed-2747397
institution National Center for Biotechnology Information
language English
publishDate 2009
publisher Dove Medical Press
record_format MEDLINE/PubMed
spelling pubmed-27473972009-09-22 Angiotensin II receptor blockers in the prevention of complications from atrial fibrillation Naccarelli, Gerald V Peacock, Frank Vasc Health Risk Manag Review Atrial fibrillation (AF) is the most common form of cardiac arrhythmia and is associated with an increased risk of cardiovascular morbidity and mortality, especially due to ischemic stroke. The occurrence of AF leads to atrial electrical and structural remodeling. The renin-angiotensin system appears to play a role in the development of atrial arrhythmias by its involvement in both of these processes. Large-scale hypertension trials and heart failure trials have indicated the potential value of angiotensin II receptor blockers in the treatment of AF. Dove Medical Press 2009 2009-09-18 /pmc/articles/PMC2747397/ /pubmed/19774220 Text en © 2009 Naccarelli and Peacock, publisher and licensee Dove Medical Press Ltd. This is an Open Access article which permits unrestricted noncommercial use, provided the original work is properly cited.
spellingShingle Review
Naccarelli, Gerald V
Peacock, Frank
Angiotensin II receptor blockers in the prevention of complications from atrial fibrillation
title Angiotensin II receptor blockers in the prevention of complications from atrial fibrillation
title_full Angiotensin II receptor blockers in the prevention of complications from atrial fibrillation
title_fullStr Angiotensin II receptor blockers in the prevention of complications from atrial fibrillation
title_full_unstemmed Angiotensin II receptor blockers in the prevention of complications from atrial fibrillation
title_short Angiotensin II receptor blockers in the prevention of complications from atrial fibrillation
title_sort angiotensin ii receptor blockers in the prevention of complications from atrial fibrillation
topic Review
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2747397/
https://www.ncbi.nlm.nih.gov/pubmed/19774220
work_keys_str_mv AT naccarelligeraldv angiotensiniireceptorblockersinthepreventionofcomplicationsfromatrialfibrillation
AT peacockfrank angiotensiniireceptorblockersinthepreventionofcomplicationsfromatrialfibrillation

Ejemplares similares